CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1 T315I+ clones in TKI-resistant CML
Titel:
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1 T315I+ clones in TKI-resistant CML
Auteur:
Schneeweiss-Gleixner, Mathias Byrgazov, Konstantin Stefanzl, Gabriele Berger, Daniela Eisenwort, Gregor Lucini, Chantal Blanche Herndlhofer, Susanne Preuner, Sandra Obrova, Klara Pusic, Petra Witzeneder, Nadine Greiner, Georg Hoermann, Gregor Sperr, Wolfgang R. Lion, Thomas Deininger, Michael Valent, Peter Gleixner, Karoline V.